Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future

Model‐informed drug development (MIDD) has a long and rich history in infectious diseases. This review describes foundational principles of translational anti‐infective pharmacology, including choice of appropriate measures of exposure and pharmacodynamic (PD) measures, patient subpopulations, and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rayner, Craig R., Smith, Patrick F., Andes, David, Andrews, Kayla, Derendorf, Hartmut, Friberg, Lena E., Hanna, Debra, Lepak, Alex, Mills, Edward, Polasek, Thomas M., Roberts, Jason A., Schuck, Virna, Shelton, Mark J., Wesche, David, Rowland‐Yeo, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014105/
https://www.ncbi.nlm.nih.gov/pubmed/33555032
http://dx.doi.org/10.1002/cpt.2198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014105/
https://www.ncbi.nlm.nih.gov/pubmed/33555032
http://dx.doi.org/10.1002/cpt.2198

Ejemplares similares